| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/01/2008 | US7393823 isolated polypeptide, glycosylated polypeptide and monoclonal antibody and their combinations; binds to the extracellular domain of EGF receptor |
| 07/01/2008 | US7393672 DNA coding for endo-β-galactosidase |
| 07/01/2008 | US7393662 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 07/01/2008 | US7393647 Kit comprising affinity agent immobilized on microtiter plate, forms complex with labeled antibody; surface array proteins; diagnosing anthrax |
| 07/01/2008 | US7393630 Immunological adjuvants and antigen entrapment; combining a submicron oil-in-water emulsion with a selected antigen entrapped in, or adsorbed to, a biodegradable microparticle, wherein the microparticle is formed from a poly(L-lactide), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) |
| 07/01/2008 | US7393541 Mycobacterial vaccine |
| 07/01/2008 | US7393540 Therapeutic peptide for prevention of microorganismal infections; enzyme inhibitors; RNA inteference; antisense agents |
| 07/01/2008 | US7393539 Therapeutic agent for prevention and treatment of bacterial infection; bactericides; genetic vaccines; immunotherapy |
| 07/01/2008 | US7393538 treating obsessions and compulsions, in particular skin picking, by local administration of Clostridial toxin; low dose, intramuscular administration of botulinum toxin |
| 07/01/2008 | US7393536 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 07/01/2008 | US7393535 Adjuvants for use in vaccines |
| 07/01/2008 | US7393534 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 07/01/2008 | US7393533 Using humanized and chimeric antibodies that specifically bind; decreases susceptibility to poxvirus, smallpox, cowpox |
| 07/01/2008 | US7393532 Treating allergic disorder by administering cytokine receptor agonist antibody or binding fragment; administered with an anticarcinogen or growth inhibitory agent |
| 07/01/2008 | US7393531 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 07/01/2008 | US7393530 IL-1-like cytokine antibodies |
| 07/01/2008 | US7393529 Antiallergens |
| 07/01/2008 | US7393525 Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
| 07/01/2008 | US7393523 Peptides for active anti-cytokine immunization |
| 06/26/2008 | WO2008077145A2 Treatment of il-1-beta related diseases |
| 06/26/2008 | WO2008077077A2 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 06/26/2008 | WO2008077027A2 Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders |
| 06/26/2008 | WO2008077022A2 Himf and btk in pulmonary, cardiac, and inflammation disorders |
| 06/26/2008 | WO2008076981A2 Inhibitors of ll-37- mediated immune reactivity to self nucleic acids |
| 06/26/2008 | WO2008076949A2 Quinazoline derivatives and methods of treatment |
| 06/26/2008 | WO2008076915A2 Treatment of pigs with pcv2 antigen |
| 06/26/2008 | WO2008076518A2 Reovirus compositions and methods of use |
| 06/26/2008 | WO2008076490A2 Histophilus somni antigens, compositions and methods of use |
| 06/26/2008 | WO2008076487A2 Antibodies and methods for making and using them |
| 06/26/2008 | WO2008076454A1 Immunogenic compositions comprising progastrin and uses thereof |
| 06/26/2008 | WO2008076379A2 Human antibodies to human delta like ligand 4 |
| 06/26/2008 | WO2008076321A1 Engineered anti-tslp antibody |
| 06/26/2008 | WO2008076278A2 Methods of cancer treatment with igf1r inhibitors |
| 06/26/2008 | WO2008076262A2 Receptor for amyloid beta and uses thereof |
| 06/26/2008 | WO2008076257A2 Treating cancer with anti-igflr antibody 19d12 = sch 717454 |
| 06/26/2008 | WO2008076157A2 Modified vaccinia ankara virus vaccine |
| 06/26/2008 | WO2008075395A2 Method for the diagnosis and/or monitoring of invasive aspergillosis |
| 06/26/2008 | WO2008075371A2 T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation |
| 06/26/2008 | WO2008075075A1 Francisella strain for live vaccine |
| 06/26/2008 | WO2008075045A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | WO2008075038A1 Binding agents to the integrin alpha-11 subunit |
| 06/26/2008 | WO2008074895A1 Circular ccr5 peptide conjugates and uses thereof |
| 06/26/2008 | WO2008074868A1 Oral delivery of polypeptides |
| 06/26/2008 | WO2008074840A2 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| 06/26/2008 | WO2008074839A2 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| 06/26/2008 | WO2008074356A1 Protein composition for inducing an immune response in a vertebrate comprising a plurality of protein variants covering the heterogeneity of a single antigen, ama1 |
| 06/26/2008 | WO2008074189A1 A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof |
| 06/26/2008 | WO2008074079A1 Identification of candidate vaccine antigens from dichelobacter nodosus |
| 06/26/2008 | WO2008054532A9 Compositions and methods for treating anthrax lethality |
| 06/26/2008 | WO2008052740A3 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours |
| 06/26/2008 | WO2008051852A3 Extracellular matrix cancer vaccine adjuvant |
| 06/26/2008 | WO2008049881A3 Polypeptides and pharmaceutical compositions comprising the same for the prevention and treatment of complications associated with infectious diseases |
| 06/26/2008 | WO2008043782A3 Modulation of cd1b or cd1d expression in autoimmune disorders |
| 06/26/2008 | WO2008036387A8 Method of treating endothelial dysfunction |
| 06/26/2008 | WO2008033571A3 Methods of diagnosing, treating, or preventing plasma cell disorders |
| 06/26/2008 | WO2008033495A3 Method for detecting and treating skin disorders |
| 06/26/2008 | WO2008030260A3 Treatment of variola viral infections using a tissue factor inhibitor |
| 06/26/2008 | WO2008016378A3 Methods to treat and/or prevent radiation- and/or chemical-induced toxicity in non-malignant tissue |
| 06/26/2008 | WO2008005828A3 PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS COMPRISING ANTIBODY MOLECULES SPECIFIC TO LAMININ-5 α3 CHAIN DOMAINS G1G2 AND USE THEREOF |
| 06/26/2008 | WO2007117686A3 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8 |
| 06/26/2008 | WO2007101676A3 Treatment, diagnosis and imaging of mantle cell lymphoma |
| 06/26/2008 | WO2007094854A3 Rna virus vaccines and methods |
| 06/26/2008 | WO2006127514A3 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c |
| 06/26/2008 | WO2005107801A3 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors and/or ucp and/or fas antibodies |
| 06/26/2008 | US20080155703 Identifying new immunomodulatory chemical entities (NICE); reacting a candidate NICE with a Tat SH3 binding domain, identifying the bound candidate NICE and determining whether it induces monocytes to differentiate into dendritic cells (DC) or regulatory macrophages (AReg); drug screening; immunotherapy |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080153108 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections |
| 06/26/2008 | US20080153104 Gene Overexpressed in Cancer |
| 06/26/2008 | US20080152738 Oil-in-water emulsions; agglutination; evaporation; lectin |
| 06/26/2008 | US20080152673 Comprising histone protein and sugar in form of amorphous solid; plant seed extract effects drying tolerance |
| 06/26/2008 | US20080152672 Methods for treating gluteal muscle |
| 06/26/2008 | US20080152671 Novel vaccination |
| 06/26/2008 | US20080152670 Attenuated; comprising at least two types of foreign genes inserted to allow expression into two different regions in a recombinant feline herpesvirus type 1 genome; one region encodes thymidine kinase; no lethal effect on the proliferation of the virus in the feline herpesvirus 1 genome |
| 06/26/2008 | US20080152668 Thymosin Alpha 1 Peptide/Polymer Conjugates |
| 06/26/2008 | US20080152667 Neurotoxin/immunoglobulin fusion for use in treatment and prevention of pain and respiratory system disorders |
| 06/26/2008 | US20080152666 Apoptosis-inducing polypeptides |
| 06/26/2008 | US20080152665 Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response |
| 06/26/2008 | US20080152664 Increasing oocyte fertilization via enhancing sperm-oocyte binding, fusion or activation |
| 06/26/2008 | US20080152663 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer |
| 06/26/2008 | US20080152662 At least two oligonucleotides linked at their 3' ends, internucleoside linkages or functionalized nucleobase or sugar to a nonnucleotidic linker, at least one oligonucleotide an immunostimulant having accessible 5' end |
| 06/26/2008 | US20080152661 Polyconjugates for In Vivo Delivery of Polynucleotides |
| 06/26/2008 | US20080152660 Anti-Angiogenic Compounds |
| 06/26/2008 | US20080152659 Using presence of deletion in complement Factor H-related 4 gene as evaluative tool in predicting aneurysm and vision defects |
| 06/26/2008 | US20080152658 Vaccine for use in prevention and treatment of hepatitis-B infection |
| 06/26/2008 | US20080152657 Donor specific antibody libraries |
| 06/26/2008 | US20080152656 Using kallikren specific inhibitor as therapeutic tool in treating cardiocascular disorders; treating soft tissue and bone trauma; tissue repair |
| 06/26/2008 | US20080152655 Using immunoglobulin specific to cytotoxic t-lymphocyte antigen-4 receptor as therapeutic in treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 06/26/2008 | US20080152654 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 06/26/2008 | US20080152653 Heterodimeric integral membrane glycoprotein specific monoclonal antibody for use in treatment of cancer, inflammatory and/or autoimmune disease |
| 06/26/2008 | US20080152652 Stem cell factor specific immunoglobulin for use in prevention and treatment of blood disorders |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152650 Methods and Compositions For Specifically Targeting Human Hepatocellular Carcinoma Cells |
| 06/26/2008 | US20080152649 Insulin-like growth factor 1 (IGF-1) receptor specific immunogloblin for use in diagnosis, prevention and treatment of cell proliferative |
| 06/26/2008 | US20080152648 Using antigen presenting cell specific immunoglobulins to treat and prevent cell proliferative disorders; tissue targeted therapy; immunotherapy |
| 06/26/2008 | US20080152647 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells |
| 06/26/2008 | US20080152646 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 06/26/2008 | US20080152645 Genetically Encoded Multifunctional Compositions Bidrectionally Transported Between Peripheral Blood and the CNS |
| 06/26/2008 | US20080152644 Using biolpolymer modulators as therapeutic tool for treatment of alzheimer's disease |
| 06/26/2008 | US20080152643 Using modulators of toll-like receptor and/or uncooridinated protein activities as therapeutic agents in treatment of diabetes, multiple sclerosis, rheumatoid arthritis and addison's diseases |